Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.

Saved in:
Bibliographic Details
Title: Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.
Authors: Arnold WD; NextGen Precision Health, University of Missouri, Columbia, United States of America., Jeppesen Morgen J; NMD Pharma A/S, Aarhus, Denmark., Thomasen PB; NMD Pharma A/S, Aarhus, Denmark., Broch-Lips M; NMD Pharma A/S, Aarhus, Denmark., Clark LA; Ohio Musculoskeletal and Neurological Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, United States of America., Groennebaek T; NMD Pharma A/S, Aarhus, Denmark., Skov M; NMD Pharma A/S, Aarhus, Denmark., Winther JB; NMD Pharma A/S, Aarhus, Denmark., Ramadan AF; Edinburgh Medical School: Biomedical Sciences, College of Medicine and Vete, University of Edinburgh, Edinburgh, United Kingdom., Rust PA; Edinburgh Medical School: Biomedical Sciences, College of Medicine and Vete, University of Edinburgh, Edinburgh, United Kingdom., Myers JH; Indian Institute of Technology, Kampur, India., Darvishi FB; NextGen Precision Health, University of Missouri, Columbia, United States of America., Dashtmian AR; NextGen Precision Health, University of Missouri, Columbia, United States of America., Fish LA; Department of Neuroscience and Carney Institute for Brain Science, Brown University, Providence, United States of America., Chugh D; Department of Neuroscience and Carney Institute for Brain Science, Brown University, Providence, United States of America., Bold J; NMD Pharma A/S, Aarhus, Denmark., Quiroz JA; NMD Pharma A/S, Aarhus, Denmark., Hutchison J; NMD Pharma A/S, Aarhus, Denmark., Nishimune H; NextGen Precision Health, University of Missouri, Columbia, United States of America., Jones RA; Edinburgh Medical School: Biomedical Sciences, College of Medicine and Vete, University of Edinburgh, Edinburgh, United Kingdom., Wang X; Department of Neuroscience, Cell Biology and Physiology, Wright State University, Dayton, United States of America., Fallon JR; Department of Neuroscience and Carney Institute for Brain Science, Brown University, Providence, United States of America., Gillingwater TH; Edinburgh Medical School: Biomedical Sciences, College of Medicine and Vete, University of Edinburgh, Edinburgh, United Kingdom., Rich MM; Department of Neuroscience, Cell Biology and Physiology, Wright State University, Dayton, United States of America., Pedersen TH; NMD Pharma A/S, Aarhus, Denmark., Clark BC; Ohio Musculoskeletal and Neurological Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, United States of America.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI190646